What are the Epidemiological Outcomes of the iPledge Program?
Evaluating the epidemiological outcomes involves assessing the reduction in isotretinoin-exposed pregnancies and subsequent birth defects. Studies have shown that the iPledge program has significantly decreased the number of exposed pregnancies, although challenges remain in ensuring 100% compliance.
